Epilepsy, a condition of recurring seizures for which a cause most frequently cannot be found, is the most common neurological disorder seen in dogs. It affects an estimated one in 20 of them. In the past, veterinarians often prescribed unapproved phenobarbital tablets from the human drug marketplace to help control seizures. But the Food and Drug Administration has just conditionally approved phenobarbital for our canine pets. The drug manufacturer has five years to be granted full approval by moving evidence for the drug’s effectiveness and safety from “expected” to fully “demonstrated.”
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Tufts Your Dog
Get the next year of Tufts Your Dog for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
